Latest News about BRTX
Recent news which mentions BRTX
EXCLUSIVE: BioRestorative Therapies' ThermoStem For Metabolic Disorders Expected To Receive Fourth Japanese Patent
May 15, 2023
Tickers
BRTX
From Benzinga
EXCLUSIVE: BioRestorative Therapies & Northwell Health Ink Trial Pact For Chronic Lower Back Pain Study
May 08, 2023
Tickers
BRTX
From Benzinga
EXCLUSIVE: BioRestorative Concludes Enrollment For Safety Run-In Component Of Cell Therapy Study For Chronic Lower Back Pain
April 24, 2023
Tickers
BRTX
From Benzinga
BioRestorative Therapies (NASDAQ: BRTX) Is Targeting The Global Obesity Epidemic With Its Recent IP Portfolio Expansion
March 30, 2023
From Benzinga
From Benzinga
EXCLUSIVE: BioRestorative Seeks Expanded FDA Approval For BRTX-100 Clinical Application, Engages Advisory Firm
March 13, 2023
Tickers
BRTX
From Benzinga
From Benzinga
From Benzinga
Why BioRestorative Therapies Stock Is Climbing Higher Today
March 02, 2023
Tickers
BRTX
From Benzinga
Dow Jumps Over 300 Points; Best Buy Profit Beats Views
March 02, 2023
From Benzinga
Why Cano Health Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 02, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 02, 2023
From Benzinga
Dow Rises 100 Points; Macy's Posts Upbeat Earnings
March 02, 2023
From Benzinga
Tickers
BRTX
From InvestorPlace
Wall Street Mixed At Open; US Weekly Jobless Claims Decline
March 02, 2023
From Benzinga
From Benzinga
EXCLUSIVE: BioRestorative To Receive Third US Patent For Metabolic ThermoStem Program
March 02, 2023
Tickers
BRTX
From Benzinga
BioRestorative Therapies Inc (NASDAQ: BRTX) Announces European Patentability Of ThermoStem® Program With Indications In Obesity And Type 2 Diabetes
February 10, 2023
From Benzinga
EXCLUSIVE: BioRestorative Poised To Receive European Patent For ThermoStem Program
February 08, 2023
Tickers
BRTX
From Benzinga
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
February 03, 2023
From Benzinga
2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
January 25, 2023
From Benzinga
EXCLUSIVE: BioRestorative Secures Funding Support For Programs Against Polycystic Ovary Syndrome
December 06, 2022
Tickers
BRTX
From Benzinga
EXCLUSIVE: BioRestorative Therapies Gets Exclusive License Rights From Regenexx For Development Of BRTX-100 Disc Program To Treat Chronic Lumbar Disc Disease
December 05, 2022
Tickers
BRTX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 23, 2022
From Benzinga
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
November 09, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.